SecBot SecBot
SC 13G ·Filed Nov 10, 2026

DGX

QUEST DIAGNOSTICS INC
NEUTRAL
Impact 3/10
Horizonimmediate Processed6d 13h ago SEC0000093751-26-000709
Passive investor 5%+ stake
Actionable Insight • Neutral

State Street's passive 5% stake adds to the existing Vanguard Group holdings. Monitor for any future 13D conversion or additional accumulation, though the 13G certification indicates no activist intent.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$258.44
T+0 close · Nov 10, 2026 · via day close
Latest settled
+0.10%
T+1 · $258.69
Vs SPY
−1.22%
α at T+1
Next horizon
T+5
in 8h
  1. T+0 · Nov 10 $258.44entry
  2. T+1 · 6d ago +0.10%α −1.22% · $258.69
  3. T+4 · todayOpen
  4. T+5 · in 8h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

State Street Corp disclosed a passive 5.0% stake in Quest Diagnostics as of September 30, 2026, holding approximately 5.56 million shares. This is a new SC 13G filing by State Street, adding to the existing Vanguard Group passive stakes on file.

Key Financial Metrics

Stake
5%
Investor
State Street Corp
Investor Type
mutual fund

Key Facts

  • State Street Corp filed a new SC 13G disclosing beneficial ownership of 5,563,421 shares of Quest Diagnostics common stock
  • The stake represents 5.0% of shares outstanding as of September 30, 2026
  • State Street certifies passive intent under Rule 13d-1(b), with no intent to influence control
  • The filing is a new position; no prior SC 13G by State Street for Quest Diagnostics appears in the cross-filing context

Financial Impact

5.0% stake valued at approximately $1.4B based on $28.1B market cap

Risk Factors

  • No material risks identified from this passive filing

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
52% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000093751-26-000709
Document: 0000093751-26-000709-index.html0000093751-26-000709
Document: 0000093751-26-000709.txt0000093751-26-000709

Track record

24 reports on DGX

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
  3. Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Viewing Entry $258.44 Now $262.21 +1.46% settles Feb 8
  5. Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  7. Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
  8. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  9. Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (10h 42m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026